Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen in the nitrogen containing substituent
Reexamination Certificate
2007-12-18
2007-12-18
Anderson, Rebecca (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Chalcogen in the nitrogen containing substituent
C546S015000, C548S411000, C548S301100, C548S357500, C514S235200, C514S278000, C514S397000, C514S406000, C514S409000
Reexamination Certificate
active
11428912
ABSTRACT:
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
REFERENCES:
patent: 5792783 (1998-08-01), Tang et al.
patent: 5834504 (1998-11-01), Tang et al.
patent: 5883113 (1999-03-01), Tang et al.
patent: 5883116 (1999-03-01), Tang et al.
patent: 5886020 (1999-03-01), Tang et al.
patent: 6541504 (2003-04-01), Andrews et al.
patent: 6559173 (2003-05-01), Andrews et al.
patent: 6699863 (2004-03-01), Andrews et al.
patent: 6747025 (2004-06-01), Andrews et al.
patent: 6765012 (2004-07-01), Andrews et al.
patent: 7005444 (2006-02-01), Andrews et al.
patent: 7015220 (2006-03-01), Andrews et al.
patent: 7060844 (2006-06-01), Andrews et al.
patent: WO 2004/037247 (2004-05-01), None
Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Science (1999), vol. 286, 531-537.
Plowman et al, “Receptor Tyrosine Kinases as Targets for Drug Intervention”, 1994, DN&P 7(6): 334-339.
Bolen, “Nonreceptor tyrosine protein kinases”, 1993, Oncogen 8: pp. 2025-2031.
Allergan Inc.
Anderson Rebecca
Baran Robert J.
German Joel B.
Voet Martin A.
LandOfFree
Kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3850392